A detailed history of Commonwealth Equity Services, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 21,453 shares of IONS stock, worth $783,678. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,453
Previous 22,669 5.36%
Holding current value
$783,678
Previous $1.08 Million 20.46%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$40.06 - $51.86 $48,712 - $63,061
-1,216 Reduced 5.36%
21,453 $859,000
Q2 2024

Jul 31, 2024

BUY
$36.45 - $47.7 $25,332 - $33,151
695 Added 3.16%
22,669 $1.08 Million
Q1 2024

Apr 29, 2024

BUY
$42.03 - $53.55 $21,519 - $27,417
512 Added 2.39%
21,974 $953,000
Q4 2023

Feb 06, 2024

SELL
$43.39 - $51.63 $347 - $413
-8 Reduced 0.04%
21,462 $1.09 Million
Q3 2023

Oct 23, 2023

BUY
$38.5 - $47.13 $34,534 - $42,275
897 Added 4.36%
21,470 $974,000
Q2 2023

Aug 10, 2023

SELL
$34.73 - $43.33 $2,257 - $2,816
-65 Reduced 0.31%
20,573 $844,000
Q1 2023

May 11, 2023

SELL
$33.58 - $41.2 $2,216 - $2,719
-66 Reduced 0.32%
20,638 $737,000
Q4 2022

Feb 07, 2023

SELL
$37.12 - $46.52 $20,156 - $25,260
-543 Reduced 2.56%
20,704 $781,000
Q3 2022

Nov 14, 2022

SELL
$36.54 - $48.66 $91,971 - $122,477
-2,517 Reduced 10.59%
21,247 $939,000
Q2 2022

Jul 19, 2022

SELL
$31.71 - $43.0 $70,681 - $95,847
-2,229 Reduced 8.58%
23,764 $879,000
Q1 2022

May 04, 2022

SELL
$29.88 - $37.04 $82,857 - $102,711
-2,773 Reduced 9.64%
25,993 $962,000
Q4 2021

Jan 31, 2022

SELL
$25.61 - $35.1 $239,504 - $328,255
-9,352 Reduced 24.53%
28,766 $875,000
Q3 2021

Oct 29, 2021

BUY
$33.54 - $40.55 $415,493 - $502,333
12,388 Added 48.15%
38,118 $1.28 Million
Q2 2021

Aug 11, 2021

BUY
$34.54 - $47.25 $262,296 - $358,816
7,594 Added 41.87%
25,730 $1.03 Million
Q1 2021

May 04, 2021

SELL
$42.51 - $63.78 $36,983 - $55,488
-870 Reduced 4.58%
18,136 $815,000
Q4 2020

Feb 11, 2021

SELL
$45.3 - $60.27 $19,841 - $26,398
-438 Reduced 2.25%
19,006 $1.07 Million
Q3 2020

Nov 05, 2020

SELL
$47.45 - $62.95 $30,747 - $40,791
-648 Reduced 3.23%
19,444 $922,000
Q2 2020

Aug 12, 2020

BUY
$46.85 - $61.05 $26,751 - $34,859
571 Added 2.93%
20,092 $1.18 Million
Q1 2020

May 11, 2020

BUY
$41.6 - $63.4 $29,536 - $45,014
710 Added 3.77%
19,521 $922,000
Q4 2019

Feb 05, 2020

SELL
$53.85 - $65.27 $42,595 - $51,628
-791 Reduced 4.04%
18,811 $1.14 Million
Q3 2019

Oct 30, 2019

BUY
$59.06 - $72.15 $2,480 - $3,030
42 Added 0.21%
19,602 $1.17 Million
Q2 2019

Jul 19, 2019

BUY
$62.09 - $86.14 $23,221 - $32,216
374 Added 1.95%
19,560 $1.26 Million
Q1 2019

May 13, 2019

BUY
$52.92 - $81.17 $13,706 - $21,023
259 Added 1.37%
19,186 $1.56 Million
Q4 2018

Feb 11, 2019

BUY
$43.37 - $59.54 $34,349 - $47,155
792 Added 4.37%
18,927 $1.02 Million
Q3 2018

Nov 06, 2018

SELL
$42.88 - $53.7 $28,300 - $35,442
-660 Reduced 3.51%
18,135 $935,000
Q2 2018

Jul 31, 2018

SELL
$40.53 - $50.7 $14,226 - $17,795
-351 Reduced 1.83%
18,795 $783,000
Q1 2018

May 14, 2018

BUY
$44.08 - $55.05 $9,080 - $11,340
206 Added 1.09%
19,146 $843,000
Q4 2017

Feb 12, 2018

BUY
$50.3 - $64.39 $952,682 - $1.22 Million
18,940
18,940 $953,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.19B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.